These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1239 related articles for article (PubMed ID: 32093786)

  • 1. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver.
    Nie P; Wang N; Pang J; Yang G; Duan S; Chen J; Xu W
    Acad Radiol; 2021 Jun; 28(6):799-807. PubMed ID: 32386828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
    Peng J; Zhang J; Zhang Q; Xu Y; Zhou J; Liu L
    Diagn Interv Radiol; 2018; 24(3):121-127. PubMed ID: 29770763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma.
    Cai W; He B; Hu M; Zhang W; Xiao D; Yu H; Song Q; Xiang N; Yang J; He S; Huang Y; Huang W; Jia F; Fang C
    Surg Oncol; 2019 Mar; 28():78-85. PubMed ID: 30851917
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver.
    Ding Z; Lin K; Fu J; Huang Q; Fang G; Tang Y; You W; Lin Z; Lin Z; Pan X; Zeng Y
    World J Surg Oncol; 2021 Jun; 19(1):181. PubMed ID: 34154624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.
    Wu S; Zheng J; Li Y; Yu H; Shi S; Xie W; Liu H; Su Y; Huang J; Lin T
    Clin Cancer Res; 2017 Nov; 23(22):6904-6911. PubMed ID: 28874414
    [No Abstract]   [Full Text] [Related]  

  • 10. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
    Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J
    Front Immunol; 2020; 11():613946. PubMed ID: 33488622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CT-based radiomics nomogram for differentiation of lympho-associated benign and malignant lesions of the parotid gland.
    Zheng YM; Xu WJ; Hao DP; Liu XJ; Gao CP; Tang GZ; Li J; Wang HX; Dong C
    Eur Radiol; 2021 May; 31(5):2886-2895. PubMed ID: 33123791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
    Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a radiomics nomogram for identifying invasiveness of pulmonary adenocarcinomas appearing as subcentimeter ground-glass opacity nodules.
    Zhao W; Xu Y; Yang Z; Sun Y; Li C; Jin L; Gao P; He W; Wang P; Shi H; Hua Y; Li M
    Eur J Radiol; 2019 Mar; 112():161-168. PubMed ID: 30777206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion.
    Sheen H; Kim JS; Lee JK; Choi SY; Baek SY; Kim JY
    Abdom Radiol (NY); 2021 Jun; 46(6):2839-2849. PubMed ID: 33388805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.